Non-brokered deal funds business development and product development
By Devika Patel
Knoxville, Tenn., Feb. 8 - Diagnos Inc. said it completed a C$1.4 million non-brokered private placement of units. The deal priced on Jan. 17.
The company sold 14 million units of one common share and one warrant at C$0.10 per unit, with each warrant exercisable at C$0.15 for 18 months. The strike price is a 36.36% premium to C$0.11, the Jan. 16 closing share price.
Wolverton Securities Ltd. was paid a finder's fee.
Proceeds will be used for business development and product development.
Based in Brossard, Quebec, Diagnos develops data-mining software used in the fields of health-care, natural resources and entertainment.
| Issuer: | Diagnos Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$1.4 million
|
| Units: | 14 million
|
| Price: | C$0.10
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | 18 months
|
| Warrant strike price: | C$0.15
|
| Agent: | Non-brokered
|
| Pricing date: | Jan. 17
|
| Settlement date: | Feb. 8
|
| Stock symbol: | TSX Venture: ADK
|
| Stock price: | C$0.11 at close Jan. 16
|
| Market capitalization: | C$6.91 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
